Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.
The efficacy and tolerability of Zinforo monotherapy has been consistently demonstrated in six large, double-blind, Phase III, randomised, controlled clinical trials: three involving adult patients with cSSTI and three in patients with CAP.2-5
System organ class |
Very common |
Common |
---|---|---|
Immune system disorders |
Rash, pruritus |
|
Nervous system disorders |
Headache, dizziness |
|
Vascular disorders |
Phlebitis |
|
Gastrointestinal disorders |
Diarrhoea†, abdominal pain, nausea, vomiting |
|
Hepatobiliary disorders |
Increased transaminases |
|
General disorders and administration site conditions |
Pyrexia, infusion site reactions (erythema, phlebitis, pain) |
|
Investigations |
Coombs Direct Test Positive |
Prescribing Information
Zinforo® (ceftaroline fosamil)
Great Britain
Zinforo 600 mg powder for concentrate for solution for infusion
Northern Ireland
Zinforo 600 mg powder for concentrate for solution for infusion
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
No
OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?